US Broker Ratings

Semler Scientific, Inc. (SMLR) Stock Analysis: A 241% Upside Potential Amidst Market Challenges

Semler Scientific, Inc. (NASDAQ: SMLR), a dynamic player in the healthcare sector, specializes in medical devices designed to enhance clinical efficiency. Notably, its flagship product, QuantaFlo,..

Immatics N.V. (IMTX) Stock Analysis: A Biotech Player with an 86.75% Upside Potential

Immatics N.V. (NASDAQ: IMTX), a Germany-based biotechnology firm, stands out in the healthcare sector with a promising focus on pioneering T cell redirecting immunotherapies aimed at..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Unpacking the 3,575.80% Revenue Growth in the Biotechnology Sector

In the ever-evolving healthcare landscape, Keros Therapeutics, Inc. (NASDAQ: KROS) has emerged as a compelling player within the biotechnology sector. With its focus on novel therapeutics..

Orthofix Medical Inc. (OFIX) Stock Analysis: Unpacking a 45% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector, specifically within the medical devices industry, is presenting a compelling case for investors seeking..

Simulations Plus, Inc. (SLP) Stock Analysis: Unveiling the 14.47% Potential Upside for Healthcare Investors

Simulations Plus, Inc. (NASDAQ: SLP), a notable player in the health information services sector, offers a compelling case for investors keen on the intersection of healthcare..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Potential Upside of 23.19% Attracts Investor Attention

Arbutus Biopharma Corporation (NASDAQ: ABUS) is positioning itself as a noteworthy player in the biotechnology sector, focusing on developing innovative treatments for infectious diseases. With a..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A Potential 266% Upside for Bold Investors

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a dynamic player in the biotechnology sector, is drawing attention with its promising stock forecast and innovative approach in the field..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Strong Buy Ratings Signal Potential 120% Upside

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to cancer treatment. Headquartered in Boulder,..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A 225% Upside Potential in the Healthcare Sector

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a prominent player in the healthcare sector, is capturing investor attention with its distinct focus on developing therapeutics for kidney diseases...

Enhabit, Inc. (EHAB) Stock Report: Navigating Healthcare with Strategic Stability and Modest Growth Potential

Enhabit, Inc. (NASDAQ: EHAB), a key player in the U.S. healthcare sector, offers a comprehensive range of home health and hospice services. With a market capitalization..

LifeMD, Inc. (LFMD) Stock Analysis: Investor Outlook on a Telehealth Innovator with a Potential 167% Upside

LifeMD, Inc. (LFMD), a burgeoning player in the healthcare sector, is steadily carving out a niche in the expanding telehealth industry. With a market capitalization of..

Nutex Health Inc. (NUTX) Stock Analysis: A Healthcare Player with a 31% Upside Potential

Nutex Health Inc. (NUTX), a prominent player in the healthcare sector, continues to capture investor attention with its impressive market performance and growth potential. With a..

Xencor, Inc. (XNCR) Stock Analysis: Unveiling a Potential 64% Upside in the Booming Biotech Sector

For investors with an eye on the dynamic field of biotechnology, Xencor, Inc. (NASDAQ: XNCR) emerges as a compelling prospect. The clinical-stage biopharmaceutical company, headquartered in..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with a Focus on Growth Potential

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector specializing in medical devices, is drawing investor attention as it navigates through a complex..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 51% Potential Upside in the Biotech Sector

Theravance Biopharma, Inc. (NASDAQ: TBPH), headquartered in South San Francisco, California, is making waves in the biotechnology industry. Focused on developing and commercializing medicines, the company..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Exploring a 58.96% Potential Upside in the Biotech Sector

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is making waves in the biotech sector with its compelling growth prospects and innovative therapies targeting chronic endocrine and neurological..

Savara, Inc. (SVRA) Stock Analysis: Strong Buy Ratings and 48.6% Upside Potential

Savara, Inc. (NASDAQ: SVRA) is gaining significant attention in the biotech investing community, thanks to its promising pipeline and robust analyst support. This clinical-stage biopharmaceutical company,..

Geron Corporation (GERN) Stock Analysis: Exploring a 158.99% Upside Potential in Biotech

In the ever-evolving biotechnology sector, Geron Corporation (NASDAQ: GERN) presents a compelling investment opportunity with a potential upside of 158.99%. Headquartered in Foster City, California, this..

Cogent Biosciences, Inc. (COGT) Stock Analysis: A Biotech Powerhouse with 22% Upside Potential

Cogent Biosciences, Inc. (NASDAQ: COGT) is capturing investor attention with its impressive market cap of $6.15 billion and a promising potential upside of 22.15%. As a..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Uncovering the 159.76% Potential Upside

For investors with an appetite for the biotech sector, Vir Biotechnology, Inc. (NASDAQ: VIR) presents a compelling opportunity. With a market capitalization of $922.4 million, this..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds